Journal Watch · Science Advances · 2026

Lactate derived from cancer-associated fibroblasts promotes alternative splicing and castration resistance in prostate cancer.

These findings reveal a metabolic-epigenetic axis linking lactate in the microenvironment to alternative splicing regulation and suggest a promising therapeutic strategy to overcome ADT resistance.

Zhao D, Mo Z, Zhang T et al.Science Advances3 min readPharma relevance 60/100

DOI: 10.1126/sciadv.ady5324PMID: 41544173Study type: research study

TL;DR

These findings reveal a metabolic-epigenetic axis linking lactate in the microenvironment to alternative splicing regulation and suggest a promising therapeutic strategy to overcome ADT resistance.

Key findings

  • Mechanistically, lactate-induced lactylation of the spliceosome component SNRPA at Lys<sup>123</sup> (K123) enhances its recognition of cis-acting elements, increases chromatin binding, and promotes androgen receptor splicing.
  • Targeting lactate transport with monocarboxylate transporter inhibitors effectively restores ADT sensitivity.
  • These findings reveal a metabolic-epigenetic axis linking lactate in the microenvironment to alternative splicing regulation and suggest a promising therapeutic strategy to overcome ADT resistance.

What they did

Here, we identified APCDD1<sup>+</sup> cancer-associated fibroblasts (CAFs) as a distinct stromal population that secretes lactate into the TME in response to androgen deprivation therapy (ADT). Lactate uptake by prostate cancer cells induces androgen receptor variant 7 expression, thereby conferring resistance to ADT.

Full abstract (original)

Background: Lactate in the tumor microenvironment (TME) is typically generated by cells exhibiting high glycolytic flux, exemplified by tumor cells. However, in glycolysis-low malignancies such as prostate cancer, stroma-derived lactate may drive noncanonical signaling and functions that remain unclear.

What they did: Here, we identified APCDD1<sup>+</sup> cancer-associated fibroblasts (CAFs) as a distinct stromal population that secretes lactate into the TME in response to androgen deprivation therapy (ADT). Lactate uptake by prostate cancer cells induces androgen receptor variant 7 expression, thereby conferring resistance to ADT.

Results & conclusions: Mechanistically, lactate-induced lactylation of the spliceosome component SNRPA at Lys<sup>123</sup> (K123) enhances its recognition of cis-acting elements, increases chromatin binding, and promotes androgen receptor splicing. Targeting lactate transport with monocarboxylate transporter inhibitors effectively restores ADT sensitivity. These findings reveal a metabolic-epigenetic axis linking lactate in the microenvironment to alternative splicing regulation and suggest a promising therapeutic strategy to overcome ADT resistance.

Abstract © the authors / Science Advances (2026). Reproduced here for discussion and indexing, with attribution. Read the original at https://doi.org/10.1126/sciadv.ady5324 · PubMed 41544173.

Why it matters for pharma & biotech

  • Directly relevant to teams in small-molecule drug discovery — the abstract reports new data in that space, so competitive and pipeline teams should read the full text.
  • As earlier-stage work, its near-term value is target validation and assay design rather than clinical decisions.
  • For searchers: the full abstract is reproduced below, so you can judge relevance before opening the publisher page.

Modalities & themes detected: small-molecule drug discovery

Limitations & what to check in the full text

  • This brief is based on the published abstract only. Effect sizes, subgroup results and safety detail in the full text may qualify the headline findings.
  • The abstract reports its conclusions qualitatively, without headline effect sizes — read the full text before citing a magnitude.

Frequently asked questions

What did this Science Advances study find?

These findings reveal a metabolic-epigenetic axis linking lactate in the microenvironment to alternative splicing regulation and suggest a promising therapeutic strategy to overcome ADT resistance.

What type of study is this?

It is a research study, published in Science Advances in 2026. Here, we identified APCDD1<sup>+</sup> cancer-associated fibroblasts (CAFs) as a distinct stromal population that secretes lactate into the TME in response to androgen deprivation therapy (ADT).

Where can I read the original paper?

The original is at the publisher via DOI 10.1126/sciadv.ady5324. PubMed ID: 41544173. BioStudioAI reproduces the abstract for discussion and links to the source.

How to cite the original: Zhao D, Mo Z, Zhang T et al.. Lactate derived from cancer-associated fibroblasts promotes alternative splicing and castration resistance in prostate cancer.. Science Advances (2026). DOI: 10.1126/sciadv.ady5324.
This brief: BioStudioAI Journal Watch, 29 October 2026. https://biostudioai.com/blog/papers/lactate-derived-from-cancer-associated-fibroblasts-promotes-alternative-dy5324/

Reading papers is step one. Analysing the data is the work.

BioStudioAI turns raw lab files into QC'd results, statistics, figures, reports and slides — hosted on your servers, every number computed, nothing typed.

Open BioStudioAI More guides